Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis
Clinical trial NCT02397382 · COMPLETED
Trial details
- NCT number
- NCT02397382
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-18
- Primary completion
- 2016-08-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.